大动脉狭窄中的循环血蛋白:与严重性,心肌反应和临床结果的关联
Eugene S J Tan1,2, Hyungwon Choi2,3, Christopher R DeFilippi4
1National University Heart Centre Singapore Singapore.
Journal of the American Heart Association
|September 30, 2024
概括
血蛋白质分析可以改善大动脉狭窄患者的风险评估. 某些炎症和免疫蛋白与更糟糕的结果和心脏功能降低有关,这需要进一步研究以更好地分层风险.
科学领域:
- 心血管医学 心血管医学
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
背景情况:
- 仅靠心声测量可能无法完全捕捉大动脉狭窄症疾病的严重程度.
- 血蛋白质组分析在大动脉狭窄患者中具有潜在的预后价值.
研究的目的:
- 研究中度至重度大动脉狭窄症患者的血蛋白质基因分析的预后价值.
- 为了识别与不良临床结果和心声回声学子组相关的蛋白质特征.
主要方法:
- 近距离延伸试验 (Olink) 分析了122名大动脉狭窄患者的183种蛋白质.
- 竞争性风险分析评估了蛋白质与复合结果 (心力衰竭住院治疗,NYHA III-IV 级进展或全因死亡率) 之间的关联.
- 网络分析探讨了蛋白质,心声学参数和N终端亲B型尿素 (NT-proBNP) 之间的关系.
主要成果:
- 减少左心室全球纵向应变与较高水平的炎症和免疫调节蛋白相关.
- 特定的回声心脏学参数 (例如,小的大动脉面积,高E/e') 与高NT-proBNP相关.
- 脂酶-C,C-X-C动机化学物质-9和介素-10受体β亚单元显示了对不良结果的最高危险比率.
结论:
- 与炎症和免疫反应相关的等离子体蛋白在有动脉狭窄患者中发生变化,左心室功能受损.
- 这些蛋白与不良临床事件有关,表明它们在风险分层中的潜在作用.
- 需要进一步的研究来将这些蛋白质生物标志物纳入大动脉狭窄风险评估策略中.
更多相关视频
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
979
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.2K
相关概念视频
01:22Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
6
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
6
01:15Aortic Regurgitation I: Introduction
3
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
3
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
63
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
01:29Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
01:17Aortic Regurgitation IV: Nursing Management
16
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
16